BCL2 and ulcer disease: In contrast, theaflavins and thearubigins correlated negatively with ulcer severity, while positively correlating with antioxidant pathway proteins (Nrf-2, HO-1), anti-apoptotic protein Bcl-2, and protective metabolites (SOD, GSH, PGE2), suggesting these components as candidate protective agents warranting further validation.